Artigos com autorizações de acesso público - Aebersold RSaiba mais
Não disponíveis em nenhum local: 36
Rever
Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions
P Picotti, R Aebersold
Nature methods 9 (6), 555-566, 2012
Autorizações: Swiss National Science Foundation
Rever
On the development of plasma protein biomarkers
S Surinova, R Schiess, R Hüttenhain, F Cerciello, B Wollscheid, ...
Journal of proteome research 10 (1), 5-16, 2011
Autorizações: Swiss National Science Foundation
Rever
Architecture and conformational switch mechanism of the ryanodine receptor
RG Efremov, A Leitner, R Aebersold, S Raunser
Nature 517 (7532), 39-43, 2015
Autorizações: German Research Foundation
Rever
Lysine-specific chemical cross-linking of protein complexes and identification of cross-linking sites using LC-MS/MS and the xQuest/xProphet software pipeline
A Leitner, T Walzthoeni, R Aebersold
Nature protocols 9 (1), 120-137, 2014
Autorizações: European Commission
Rever
Proteomic and interactomic insights into the molecular basis of cell functional diversity
I Bludau, R Aebersold
Nature Reviews Molecular Cell Biology 21 (6), 327-340, 2020
Autorizações: Swiss National Science Foundation, European Commission
Rever
Quantitative measurements of N‐linked glycoproteins in human plasma by SWATH‐MS
Y Liu, R Hüttenhain, S Surinova, LCJ Gillet, J Mouritsen, R Brunner, ...
Proteomics 13 (8), 1247-1256, 2013
Autorizações: Swiss National Science Foundation, US National Institutes of Health
Rever
Comparative analysis reveals conserved protein phosphorylation networks implicated in multiple diseases
CSH Tan, B Bodenmiller, A Pasculescu, M Jovanovic, MO Hengartner, ...
Science signaling 2 (81), ra39-ra39, 2009
Autorizações: Swiss National Science Foundation, US National Institutes of Health …
Rever
Mass spectrometry supported determination of protein complex structure
T Walzthoeni, A Leitner, F Stengel, R Aebersold
Current opinion in structural biology 23 (2), 252-260, 2013
Autorizações: Wellcome Trust
Rever
Characterization of a DNA exit gate in the human cohesin ring
PJ Huis in’t Veld, F Herzog, R Ladurner, IF Davidson, S Piric, E Kreidl, ...
Science 346 (6212), 968-972, 2014
Autorizações: Austrian Science Fund
Rever
Standard guidelines for the chromosome-centric human proteome project
YK Paik, GS Omenn, M Uhlen, S Hanash, G Marko-Varga, R Aebersold, ...
Journal of proteome research 11 (4), 2005-2013, 2012
Autorizações: US National Institutes of Health
Rever
Assessment of a method to characterize antibody selectivity and specificity for use in immunoprecipitation
E Marcon, H Jain, A Bhattacharya, H Guo, S Phanse, S Pu, G Byram, ...
Nature methods 12 (8), 725-731, 2015
Autorizações: US National Institutes of Health, Canadian Institutes of Health Research …
Rever
Directed mass spectrometry: towards hypothesis-driven proteomics
A Schmidt, M Claassen, R Aebersold
Current opinion in chemical biology 13 (5-6), 510-517, 2009
Autorizações: Swiss National Science Foundation, US National Institutes of Health
Rever
Advancing translational research and precision medicine with targeted proteomics
AC Uzozie, R Aebersold
Journal of proteomics 189, 1-10, 2018
Autorizações: Swiss National Science Foundation
Rever
Interactome of the amyloid precursor protein APP in brain reveals a protein network involved in synaptic vesicle turnover and a close association with Synaptotagmin-1
BM Kohli, D Pflieger, LN Mueller, G Carbonetti, R Aebersold, RM Nitsch, ...
Journal of proteome research 11 (8), 4075-4090, 2012
Autorizações: Swiss National Science Foundation
Rever
Phosphoproteomic analysis identifies proteins involved in transcription-coupled mRNA decay as targets of Snf1 signaling
KA Braun, S Vaga, KM Dombek, F Fang, S Palmisano, R Aebersold, ...
Science signaling 7 (333), ra64-ra64, 2014
Autorizações: US National Institutes of Health
Rever
Quantitative analysis of protein phosphorylation on a system-wide scale by mass spectrometry-based proteomics
B Bodenmiller, R Aebersold
Methods in enzymology 470, 317-334, 2010
Autorizações: US National Institutes of Health
Rever
Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome
M Kälin, I Cima, R Schiess, N Fankhauser, T Powles, P Wild, A Templeton, ...
European urology 60 (6), 1235-1243, 2011
Autorizações: Swiss National Science Foundation
Rever
PCprophet: a framework for protein complex prediction and differential analysis using proteomic data
A Fossati, C Li, F Uliana, F Wendt, F Frommelt, P Sykacek, M Heusel, ...
Nature methods 18 (5), 520-527, 2021
Autorizações: Swiss National Science Foundation, National Health and Medical Research …
Rever
Protein expression changes in ovarian cancer during the transition from benign to malignant
S Waldemarson, M Krogh, A Alaiya, U Kirik, K Schedvins, G Auer, ...
Journal of proteome research 11 (5), 2876-2889, 2012
Autorizações: Swiss National Science Foundation
Rever
Minimal sample requirement for highly multiplexed protein quantification in cell lines and tissues by PCT‐SWATH mass spectrometry
S Shao, T Guo, CC Koh, S Gillessen, M Joerger, W Jochum, R Aebersold
Proteomics 15 (21), 3711-3721, 2015
Autorizações: Swiss National Science Foundation, National Natural Science Foundation of …
As informações de publicação e financiamento são determinadas automaticamente por um programa informático.